Entry - #604232 - LEBER CONGENITAL AMAUROSIS 3; LCA3 - OMIM
# 604232

LEBER CONGENITAL AMAUROSIS 3; LCA3


Other entities represented in this entry:

RETINITIS PIGMENTOSA 94, VARIABLE AGE AT ONSET, INCLUDED; RP94, INCLUDED

Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q31.3 Retinitis pigmentosa 94, variable age at onset, autosomal recessive 604232 AR 3 SPATA7 609868
14q31.3 Leber congenital amaurosis 3 604232 AR 3 SPATA7 609868
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
HEAD & NECK
Eyes
- Reduced vision, severe, from birth (LCA)
- Progressive reduction in visual acuity (RP)
- Nystagmus (vertical, horizontal, and/or rotatory)
- Sluggish pupillary responses
- Night blindness
- Hypermetropic astigmatism
- Strabismus (esotropia and exotropia)
- Constricted visual fields
- Color vision defects (in some patients)
- Optic disc pallor
- Attenuated retinal vasculature
- Atrophy of retinal pigment epithelium
- Chorioretinal atrophy
- Choroidal sclerosis (in 1 patient)
- Bone-spicule pigmentation
- Pigmentary deposits
- Severely reduced or extinguished responses on electroretinography
- Thinning of outer nuclear layer on optical coherence tomography
MISCELLANEOUS
- Age at onset ranges from infancy (LCA) to adulthood (RP)
- Inter- and intrafamilial variability
MOLECULAR BASIS
- Caused by mutation in the spermatogenesis-associated protein-7 gene (SPATA7, 609868.0001)
Retinitis pigmentosa - PS268000 - 100 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.11 Retinitis pigmentosa 59 AR 3 613861 DHDDS 608172
1p36.11 ?Congenital disorder of glycosylation, type 1bb AR 3 613861 DHDDS 608172
1p34.1 Retinitis pigmentosa 76 AR 3 617123 POMGNT1 606822
1p31.3 Retinitis pigmentosa 20 AR 3 613794 RPE65 180069
1p31.3 Retinitis pigmentosa 87 with choroidal involvement AD 3 618697 RPE65 180069
1p22.1 Retinitis pigmentosa 19 AR 3 601718 ABCA4 601691
1p13.3 Retinitis pigmentosa 32 AR 3 609913 CLCC1 617539
1q21.2 Retinitis pigmentosa 18 AD 3 601414 PRPF3 607301
1q22 Retinitis pigmentosa 35 AR 3 610282 SEMA4A 607292
1q31.3 Retinitis pigmentosa-12 AR 3 600105 CRB1 604210
1q32.3 ?Retinitis pigmentosa 67 AR 3 615565 NEK2 604043
1q41 Retinitis pigmentosa 39 AR 3 613809 USH2A 608400
2p23.3 Retinitis pigmentosa 75 AR 3 617023 AGBL5 615900
2p23.3 ?Retinitis pigmentosa 58 AR 3 613617 ZNF513 613598
2p23.3 Retinitis pigmentosa 71 AR 3 616394 IFT172 607386
2p23.2 Retinitis pigmentosa 54 AR 3 613428 PCARE 613425
2p15 Retinitis pigmentosa 28 AR 3 606068 FAM161A 613596
2q11.2 Retinitis pigmentosa 33 AD 3 610359 SNRNP200 601664
2q13 Retinitis pigmentosa 38 AR 3 613862 MERTK 604705
2q31.3 Retinitis pigmentosa 26 AR 3 608380 CERKL 608381
2q37.1 Retinitis pigmentosa 47, autosomal recessive AR 3 613758 SAG 181031
2q37.1 Retinitis pigmentosa 96, autosomal dominant AD 3 620228 SAG 181031
3q11.2 Retinitis pigmentosa 55 AR 3 613575 ARL6 608845
3q12.3 Retinitis pigmentosa 56 AR 3 613581 IMPG2 607056
3q22.1 Retinitis pigmentosa 4, autosomal dominant or recessive AD, AR 3 613731 RHO 180380
3q25.1 Retinitis pigmentosa 61 3 614180 CLRN1 606397
3q26.2 Retinitis pigmentosa 68 AR 3 615725 SLC7A14 615720
4p16.3 Retinitis pigmentosa-40 AR 3 613801 PDE6B 180072
4p15.32 Retinitis pigmentosa 93 AR 3 619845 CC2D2A 612013
4p15.32 Retinitis pigmentosa 41 AR 3 612095 PROM1 604365
4p12 Retinitis pigmentosa 49 AR 3 613756 CNGA1 123825
4q32-q34 Retinitis pigmentosa 29 AR 2 612165 RP29 612165
5q32 Retinitis pigmentosa 43 AR 3 613810 PDE6A 180071
6p24.2 Retinitis pigmentosa 62 AR 3 614181 MAK 154235
6p21.31 Retinitis pigmentosa 14 AR 3 600132 TULP1 602280
6p21.1 Retinitis pigmentosa 48 AD 3 613827 GUCA1B 602275
6p21.1 Leber congenital amaurosis 18 AD, AR, DD 3 608133 PRPH2 179605
6p21.1 Retinitis pigmentosa 7 and digenic form AD, AR, DD 3 608133 PRPH2 179605
6q12 Retinitis pigmentosa 25 AR 3 602772 EYS 612424
6q14.1 Retinitis pigmentosa 91 AD 3 153870 IMPG1 602870
6q23 Retinitis pigmentosa 63 AD 2 614494 RP63 614494
7p21.1 ?Retinitis pigmentosa 85 AR 3 618345 AHR 600253
7p15.3 Retinitis pigmentosa 42 AD 3 612943 KLHL7 611119
7p14.3 ?Retinitis pigmentosa 9 AD 3 180104 RP9 607331
7q32.1 Retinitis pigmentosa 10 AD 3 180105 IMPDH1 146690
7q34 Retinitis pigmentosa 86 AR 3 618613 KIAA1549 613344
8p23.1 Retinitis pigmentosa 88 AR 3 618826 RP1L1 608581
8p11.21-p11.1 Retinitis pigmentosa 73 AR 3 616544 HGSNAT 610453
8q11.23-q12.1 Retinitis pigmentosa 1 AD, AR 3 180100 RP1 603937
8q22.1 Cone-rod dystrophy 16 AR 3 614500 CFAP418 614477
8q22.1 Retinitis pigmentosa 64 AR 3 614500 CFAP418 614477
9p21.1 Retinitis pigmentosa 31 AD 3 609923 TOPORS 609507
9q32 Retinitis pigmentosa 70 AD 3 615922 PRPF4 607795
10q11.22 ?Retinitis pigmentosa 66 AR 3 615233 RBP3 180290
10q22.1 Retinitis pigmentosa 92 AR 3 619614 HKDC1 617221
10q22.1 Retinitis pigmentosa 79 AD 3 617460 HK1 142600
10q23.1 Retinitis pigmentosa 65 AR 3 613660 CDHR1 609502
10q23.1 Cone-rod dystrophy 15 AR 3 613660 CDHR1 609502
10q23.1 Macular dystrophy, retinal AR 3 613660 CDHR1 609502
10q23.1 Retinitis pigmentosa 44 3 613769 RGR 600342
10q24.32 Retinitis pigmentosa 83 AD 3 618173 ARL3 604695
11p11.2 Retinitis pigmentosa 72 AR 3 616469 ZNF408 616454
11q12.3 Retinitis pigmentosa-50 3 613194 BEST1 607854
11q12.3 Retinitis pigmentosa, concentric 3 613194 BEST1 607854
11q12.3 Retinitis pigmentosa 7, digenic form AD, AR, DD 3 608133 ROM1 180721
14q11.2-q12 Retinitis pigmentosa 27 AD 3 613750 NRL 162080
14q24.1 Leber congenital amaurosis 13 AD, AR 3 612712 RDH12 608830
14q24.3 ?Retinitis pigmentosa 81 AR 3 617871 IFT43 614068
14q31.3 Retinitis pigmentosa 94, variable age at onset, autosomal recessive AR 3 604232 SPATA7 609868
14q31.3 Leber congenital amaurosis 3 AR 3 604232 SPATA7 609868
14q31.3 ?Retinitis pigmentosa 51 AR 3 613464 TTC8 608132
15q23 Retinitis pigmentosa 37 AD, AR 3 611131 NR2E3 604485
15q25.1 Retinitis pigmentosa 90 AR 3 619007 IDH3A 601149
16p13.3 Retinitis pigmentosa 80 AR 3 617781 IFT140 614620
16p12.3-p12.1 Retinitis pigmentosa 22 2 602594 RP22 602594
16q13 Retinitis pigmentosa 74 AR 3 616562 BBS2 606151
16q13 Retinitis pigmentosa with or without situs inversus AR 3 615434 ARL2BP 615407
16q21 Retinitis pigmentosa 45 AR 3 613767 CNGB1 600724
16q22.2 Retinitis pigmentosa 84 AR 3 618220 DHX38 605584
17p13.3 Retinitis pigmentosa 13 AD 3 600059 PRPF8 607300
17q23.2 Retinitis pigmentosa 17 AD 4 600852 RP17 600852
17q25.1 Retinitis pigmentosa 36 3 610599 PRCD 610598
17q25.3 Retinitis pigmentosa 30 3 607921 FSCN2 607643
17q25.3 Retinitis pigmentosa 57 AR 3 613582 PDE6G 180073
19p13.3 Retinitis pigmentosa 77 AR 3 617304 REEP6 609346
19p13.3 Retinitis pigmentosa 95 AR 3 620102 RAX2 610362
19p13.2 Retinitis pigmentosa 78 AR 3 617433 ARHGEF18 616432
19q13.42 Retinitis pigmentosa 11 AD 3 600138 PRPF31 606419
20p13 Retinitis pigmentosa 46 AR 3 612572 IDH3B 604526
20p11.23 Retinitis pigmentosa 69 AR 3 615780 KIZ 615757
20q11.21 Retinitis pigmentosa 89 AD 3 618955 KIF3B 603754
20q13.33 Retinitis pigmentosa 60 AD 3 613983 PRPF6 613979
Xp22.2 ?Retinitis pigmentosa 23 XLR 3 300424 OFD1 300170
Xp21.3-p21.2 ?Retinitis pigmentosa, X-linked recessive, 6 XL 2 312612 RP6 312612
Xp11.4 Retinitis pigmentosa 3 XL 3 300029 RPGR 312610
Xp11.3 Retinitis pigmentosa 2 XL 3 312600 RP2 300757
Xq26-q27 Retinitis pigmentosa 24 2 300155 RP24 300155
Xq28 Retinitis pigmentosa 34 2 300605 RP34 300605
Chr.Y Retinitis pigmentosa, Y-linked YL 2 400004 RPY 400004
Not Mapped Retinitis pigmentosa AR 268000 RP 268000
Leber congenital amaurosis - PS204000 - 26 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.22 Leber congenital amaurosis 9 AR 3 608553 NMNAT1 608700
1p31.3 Leber congenital amaurosis 2 AR 3 204100 RPE65 180069
1q31.3 Leber congenital amaurosis 8 AR 3 613835 CRB1 604210
1q32.3 Leber congenital amaurosis 12 AR 3 610612 RD3 180040
2q37.1 Leber congenital amaurosis 16 AR 3 614186 KCNJ13 603208
4q32.1 Retinitis pigmentosa, juvenile AR 3 613341 LRAT 604863
4q32.1 Retinal dystrophy, early-onset severe AR 3 613341 LRAT 604863
4q32.1 Leber congenital amaurosis 14 AR 3 613341 LRAT 604863
6p21.31 Leber congenital amaurosis 15 AR 3 613843 TULP1 602280
6p21.1 Retinitis pigmentosa 7 and digenic form AD, AR, DD 3 608133 PRPH2 179605
6p21.1 Leber congenital amaurosis 18 AD, AR, DD 3 608133 PRPH2 179605
6q14.1 Leber congenital amaurosis 5 AR 3 604537 LCA5 611408
6q16.2 ?Leber congenital amaurosis 19 AR 3 618513 USP45 618439
7q32.1 Leber congenital amaurosis 11 AD 3 613837 IMPDH1 146690
8q22.1 Leber congenital amaurosis 17 AR 3 615360 GDF6 601147
11q12.3 Retinitis pigmentosa 7, digenic form AD, AR, DD 3 608133 ROM1 180721
12q21.32 Leber congenital amaurosis 10 3 611755 CEP290 610142
14q11.2 Leber congenital amaurosis 6 AR 3 613826 RPGRIP1 605446
14q24.1 Leber congenital amaurosis 13 AD, AR 3 612712 RDH12 608830
14q31.3 Retinitis pigmentosa 94, variable age at onset, autosomal recessive AR 3 604232 SPATA7 609868
14q31.3 Leber congenital amaurosis 3 AR 3 604232 SPATA7 609868
17p13.2 Cone-rod dystrophy AD, AR 3 604393 AIPL1 604392
17p13.2 Retinitis pigmentosa, juvenile AD, AR 3 604393 AIPL1 604392
17p13.2 Leber congenital amaurosis 4 AD, AR 3 604393 AIPL1 604392
17p13.1 Leber congenital amaurosis 1 AR 3 204000 GUCY2D 600179
19q13.33 Leber congenital amaurosis 7 3 613829 CRX 602225

TEXT

A number sign (#) is used with this entry because Leber congenital amaurosis-3 (LCA3) and a form of retinitis pigmentosa with variable age at onset (RP94) are caused by homozygous or compound heterozygous mutation in the SPATA7 gene (609868) on chromosome 14q31.


Description

Autosomal recessive childhood-onset severe retinal dystrophy is a heterogeneous group of disorders affecting rod and cone photoreceptors simultaneously. The most severe cases are termed Leber congenital amaurosis, whereas the less aggressive forms are usually considered retinitis pigmentosa (Gu et al., 1997). SPATA7-associated retinopathy shows a variable age at onset, ranging from infancy to adulthood, as well as phenotypic variability, including intrafamilial differences (Wang et al., 2009; Avila-Fernandez et al., 2011; Feldhaus et al., 2018; Sengillo et al., 2018).

Mackay et al. (2011) concluded that SPATA7 retinopathy is an infantile-onset severe cone-rod dystrophy with early extensive peripheral retinal atrophy but with variable foveal involvement.

For a general phenotypic description and a discussion of genetic heterogeneity of Leber congenital amaurosis, see LCA1 (204000); for retinitis pigmentosa, see 268000.

Reviews

Kannabiran (2020) reviewed reported SPATA7 mutations and the associated phenotypes. The author noted that there were no clear-cut correlations between genotype and phenotype, and that phenotypic heterogeneity had been observed among patients with the same mutation. Clinical variability was also often seen in patients with SPATA7 mutations, with some phenotypes resembling cone-rod dystrophy or choroideremia.


Clinical Features

Stockton et al. (1998) reported a large consanguineous Saudi Arabian kindred (KKESH-019) segregating Leber congenital amaurosis. In addition to poor visual acuity (typically less than 5/200), affected individuals manifested moderate midfacial hypoplasia with enophthalmos, complex vertical, horizontal, and rotatory nystagmus present from early life, moderate hypermetropic refractive errors with astigmatism, and various presentations of esotropia and exotropia. At least 4 individuals had hospital-based electroretinograms (ERGs) which were nonrecordable in both photopic and scotopic components in the first 2 years of life.

Li et al. (2009) reported a Saudi Arabian family (KKESH-060) segregating LCA. The 3 affected sibs had poor vision, nonrecordable ERGs, hypermetropic astigmatism, and infantile nystagmus. Two also showed neuroretinal atrophy and markedly attenuated vessels of the fundi.

Mackay et al. (2011) reported affected members of 5 unrelated families with LCA3. The retina had widespread retinal pigment epithelial atrophy, with minimal pigment migration into the neurosensory retina. Fundus autofluorescence (FAF) imaging showed a parafoveal annulus of increased autofluorescence. High-definition optical coherence tomography (OCT) showed preservation of the inner/outer segment junction at the fovea.

Retinitis Pigmentosa 94, with Variable Age at Onset

Wang et al. (2009) reported 2 unrelated patients with juvenile-onset retinitis pigmentosa (RP) and mutation in the SPATA7 gene. The first was a 7-year-old Portuguese girl (patient 28608) who had excellent (20/20) visual acuity without nystagmus. She developed nyctalopia before age 2 and had 5-degree visual fields on Goldmann perimetry with nondetectable ERGs. The second patient was a French-Canadian man (patient 1348) who was found to have hand-motion vision at age 55 years. He reported initially normal vision in childhood that declined, with the development of night blindness and nystagmus. Examination revealed advanced retinal pigmentary degeneration, with narrow arterioles, optic disc pallor, and mild maculopathy. ERGs were nondetectable and visual fields were reduced to 5 degrees with the V4e target.

Avila-Fernandez et al. (2011) reported 2 Spanish sibs from a consanguineous family with late-onset RP and mutation in the SPATA7 gene. The proband developed night blindness at age 25 years, at which time visual fields were normal. At age 29, she experienced loss of peripheral visual fields, and reexamination showed narrowed retinal vessels and bone-spicule pigmentation in the peripheral retina, with subnormal rod responses on ERG. At age 31, her visual field was limited to 10 degrees, and the ERG showed severely decreased a- and b-wave responses with both scotopic and photopic stimulation. Her affected sib was asymptomatic, but mixed ERG at age 26 showed a moderate reduction in the amplitude of the a-wave and delay in both a- and b-wave latency bilaterally.

Clinical Variability

Matsui et al. (2016) studied a Hispanic boy who presented with a cone-rod dystrophy phenotype that developed into late-stage RP, and who had mutation in the SPATA7 gene. The proband was diagnosed with RP at age 7 years, with retinal pigmentary changes on funduscopy and an abnormal ERG. At age 9, best-corrected visual acuity (BCVA) was 20/25 and 20/32, funduscopy showed a waxy optic disc, minimal vessel attenuation, bull's eye-like change in the macula, and a tigroid appearance of the peripheral retina. Full-field ERG showed reduced rod-mediated responses with nondetectable cone-mediated responses. Visual fields were severely limited to a small central island and midperipheral island of vision. The ERG and visual field findings were consistent with a cone-rod dystrophy. Follow-up over 12 years showed progressive loss of peripheral vision, and by age 17 years, only central vision was detectable. ERG at ages 17 and 21 years showed nondetectable rod function, whereas cone function remained measurable at fixation. OCT showed progressive thinning of the outer nuclear layer (ONL) and rod outer segments (ROS), with the ONL eventually barely detectable and the ROS unmeasurable.

Sengillo et al. (2018) reported a 63-year-old man who had RP with a choroideremia-like phenotype and mutation in the SPATA7 gene. The proband, who had a long history of progressive nyctalopia, visual field constriction, and reduction in visual acuity, and was diagnosed with RP at 31 years of age, presented with a recent subacute decrease in visual acuity of the left eye accompanied by a halo effect around objects. Upon examination, he had BCVAs of 20/30 and 20/60 in the right and left eyes, respectively, and funduscopy showed extensive chorioretinal degeneration of the peripheral retina, progressing toward the macula which contained islands of spared RPE. FAF imaging revealed widespread continuous loss of RPE encroaching on the central macula in both eyes. Spectral domain OCT confirmed those findings, and showed extensive degeneration and sclerosis of the choroid in areas of RPE loss, with focal areas of RPE thickening that were more prominent in the left eye. Full-field ERG revealed completely extinguished scotopic and photopic responses. On follow-up 2 years later, the proband reported no changes in vision, and examination showed BCVAs of 20/25 and 20/60, but progression of disease was evident on SD-OCT and FAF, with FAF confirming a reduction in the area of centrally spared RPE compared to baseline.

Feldhaus et al. (2018) reported a German brother and sister with retinal degeneration and mutation in the SPATA7 gene. Upon examination, the 52-year-old brother was more severely affected than his 48-year-old sister. BCVA in the brother was 20/100 and 20/175, with concentric narrowing to 2 degrees. His sister had BCVAs of 20/160 bilaterally, with visual field narrowing to 40 degrees. ERG responses in the brother were nondetectable, with significantly elevated thresholds for dark adaptation, whereas ERG in the sister showed reduced cone and rod responses, with better-preserved rod function and moderately elevated thresholds for dark adaptation. Color vision testing showed color confusion without assignment to a specific axis in the brother, and a tritanomalous defect in the sister. Both had bone spicule-like pigmentation, more prominent in the brother, and both had attenuated arterioles and optic disc pallor. Central retinal thickness was normal in the brother and reduced in the sister. The clinical diagnosis in the brother was rod-cone dystrophy, whereas in the sister it was cone-rod dystrophy. Age at onset was not reported.


Mapping

Stockton et al. (1998) used a DNA pooling strategy comparing the genotypes of affected to unaffected control pools in a genomewide search for identity by descent in a consanguineous Saudi Arabian LCA family (KKESH-019). A shift to homozygosity was observed in the affected DNA pool compared with the control pool at linked markers D14S606 and D14S610. Testing of markers closely linked to and flanking these loci confirmed linkage with a maximum lod score of 13.29 at theta = 0.0. From these data, the LCA locus, designated LCA3, was assigned to 14q24. This locus and the previously identified loci for LCA were excluded in other Saudi Arabian pedigrees, indicating yet further genetic heterogeneity in LCA.

Using short tandem repeat markers in a Saudi Arabian family (KKESH-060) segregating LCA, Li et al. (2009) found linkage of the disorder to the LCA3 locus at 14q24 (lod score of 3.0). All 3 affected members were homozygous between markers D14S61 and D14S1066, a 13.4-Mb interval, whereas unaffected family members were heterozygous or wildtype. Li et al. (2009) noted that the haplotype in their family was different from that in the family reported by Stockton et al. (1998).

By whole-genome SNP analysis and fine mapping of the distal boundary of the LCA3 locus in 1 affected subject from each of the 2 families with LCA previously studied by Stockton et al. (1998) and Li et al. (2009), Wang et al. (2009) refined the critical region of homozygosity to 3.8 Mb between markers D14S1022 and D14S1005 on chromosome 14q31.3. The critical region contained 9 candidate genes.

In 2 Spanish sibs from a consanguineous family with typical late-onset RP, Avila-Fernandez et al. (2011) performed genomewide linkage analysis followed by homozygosity mapping and identified a 3.7-Mb region on chromosome 14 with a lod score of 2.8 that encompassed the SPATA7 gene.


Molecular Genetics

Leber Congenital Amaurosis 3

In 2 unrelated Saudi Arabian families (KKESH-019 and KKESH-060) with Leber congenital amaurosis (LCA3; 604232) previously reported by Stockton et al. (1998) and Li et al. (2009), respectively, Wang et al. (2009) sequenced 9 candidate genes and identified a homozygous mutation in the SPATA7 gene (R108X; 609868.0001) in family KKESH-060 that segregated with the disease and was not found in 50 Saudi Arabian and 100 European samples. Mutation analysis in additional patients revealed homozygosity for the same R108X mutation in a Dutch LCA patient as well as a frameshift mutation in another LCA patient of Middle Eastern origin (609868.0002). Wang et al. (2009) also identified homozygous SPATA7 mutations in 2 patients with juvenile-onset retinitis pigmentosa (see later).

Mackay et al. (2011) screened all coding exons in the SPATA7 gene in 141 patients diagnosed with LCA or early childhood-onset severe retinal dystrophy and identified 4 disease-causing mutations in 5 families. They concluded that mutations in SPATA7 are a rare cause of childhood retinal dystrophy, accounting for 1.7% of disease in their cohort. Four consanguineous families with LCA, 3 of Pakistani and 1 of Bangladeshi origin, had a homozygous mutation in exon 5 (609868.0007) or exon 8 (609868.0002). In a nonconsanguineous British Caucasian family, 2 brothers had compound heterozygous mutations, one in exon 5 (609868.0005) and the other in exon 12 (609868.0006). One of the brothers had clinical features consistent with LCA, having severe visual loss from early infancy, pendular nystagmus, and sluggish pupillary responses. His brother had a milder phenotype with onset of nystagmus at 8 weeks of age. He was able to fix and follow at this age. When older, he was noted to have severe nyctalopia and constricted visual fields. These symptoms deteriorated significantly from 14 years of age.

Retinitis Pigmentosa 94, Variable Age at Onset

In 2 patients with juvenile-onset retinitis pigmentosa (RP94; see 604232), Wang et al. (2009) identified homozygosity for 2 different different nonsense and frameshift mutations in the SPATA7 gene (609868.0003 and 609868.0004, respectively). Wang et al. (2009) noted that, consistent with the observation that LCA has a more severe clinical phenotype than juvenile RP, the nonsense mutations associated with LCA are located in the middle of the SPATA7 coding region, whereas those associated with juvenile RP are located in the last 2 exons of SPATA7.

In 2 Spanish sibs from a consanguineous family with typical late-onset RP mapping to the SPATA7 locus on chromosome 14, Avila-Fernandez et al. (2011) identified homozygosity for the R85X mutation in the SPATA7 gene (609868.0007), previously reported in affected individuals from 3 families with LCA (Mackay et al., 2011). Avila-Fernandez et al. (2011) suggested that the phenotypic variability might be explained by modifier alleles contributing to penetrance and expressivity, or intronic variants influencing severity.

In a 21-year-old Hispanic man with retinal degeneration that had progressed over 12 years from a cone-rod dystrophy phenotype to a late-stage RP phenotype, Matsui et al. (2016) screened 163 retinal disease-associated genes and identified homozygosity for a 1-bp deletion in the SPATA7 gene (609868.0008).

In a 63-year-old man who had severe RP associated with prominent RPE atrophy and choroidal sclerosis, Sengillo et al. (2018) performed whole-exome sequencing and identified compound heterozygosity for mutations in the SPATA7 gene: a missense mutation (Y367C; 609868.0009) and a 2-bp deletion (609868.0010). An unaffected family member was heterozygous for 1 of the variants, both of which were present at very low minor allele frequency (less than 0.00003) in the gnomAD database. The authors stated that future studies were needed to discern whether unidentified genetic modifiers were involved or whether this represented a phenotypic subset of SPATA7-associated retinal degeneration.

In a German brother and sister with retinal degeneration, diagnosed as rod-cone and cone-rod dystrophy, respectively, Feldhaus et al. (2018) analyzed genomic DNA using a panel of 286 retinal disease-associated genes and identified homozygosity for a missense mutation in the SPATA7 gene (I371T; 609868.0011). The variant, which was found at low minor allele frequency (0.0003249) in the ExAC database, was present in heterozygosity in their 85-year-old mother, who had normal age-related findings on all tests; DNA was unavailable from the father. The authors noted that although the sibs were homozygous for the same mutation, they exhibited phenotypic variability, and thus genotype/phenotype correlation remained difficult.


Nomenclature

Leber congenital amaurosis-13 (612712), which is caused by mutation in the RDH12 gene (608830) on chromosome 14q23.3, was originally thought to be the same as LCA3. However, affected members of the Saudi Arabian family reported by Stockton et al. (1998) do not have mutations in the RDH12 gene.


Animal Model

Eblimit et al. (2015) generated Spata7-knockout mice and observed severe early-onset retinal defects, with a marked reduction in the thickness of the outer nuclear layer compared to wildtype mice. The loss in thickness was progressive, suggesting that photoreceptor cells degenerate in the absence of Spata7 function; other cell types in the mutant retinas were unaffected. Quantification of cone and rod cells per unit area indicated that cone photoreceptor degeneration proceeds at a substantially lower rate compared to rods in Spata7-mutant retinas. Transmission electron microscopy revealed shortened outer segments and disorganization of the disc membranes in mutant retinas compared to wildtype retinas, where the discs were well-organized into stacks. Analysis of rod and cone electroretinography (ERG) responses in the Spata7-null mice showed a decline in rod responses by postnatal day (P) 15 that became more pronounced with age, whereas cone-mediated responses showed only a slight age-dependent decline. Rod function was almost undetectable by age 12 months.

Eblimit et al. (2018) generated a conditional SPATA7-knockout allele to determine which cell type requires Spata7 function for photoreceptor survival. In Spata7 photoreceptor-specific conditional knockout mice, both rod and cone photoreceptor dysfunction and degeneration was observed, characterized by progressive thinning of the outer nuclear layer and reduced response to light. However, RPE-specific deletion of Spata7 did not impair retinal function or cell survival. The authors noted that the alteration in both rod and cone function resulting from loss of Spata7 in photoreceptors was consistent with the clinical phenotypes of LCA and RP observed in patients with SPATA7 mutations.


REFERENCES

  1. Avila-Fernandez, A., Corton, M., Lopez-Molina, M. I., Martin-Garrido, E., Cantalapiedra, D., Fernandez-Sanchez, R., Blanco-Kelly, F., Riveiro-Alvarez, R., Tatu, S. D., Trujillo-Tiebas, M. J., Garcia-Sandoval, B., Ayuso, C., Cremers, F. P. M. Late onset retinitis pigmentosa. Ophthalmology 118: 2523-2524, 2011. [PubMed: 22136677, related citations] [Full Text]

  2. Eblimit, A., Agrawal, S. A., Thomas, K., Anastassov, I. A., Abulikemu, T., Moayedi, Y., Mardon, G., Chen, R. Conditional loss of Spata7 in photoreceptors causes progressive retinal degeneration in mice. Exp. Eye Res. 166: 120-130, 2018. Note: Erratum: Exp Eye Res. 171: 119, 2018. [PubMed: 29100828, images, related citations] [Full Text]

  3. Eblimit, A., Nguyen, T.-M. T., Chen, Y., Esteve-Rudd, J., Zhong, H., Letteboer, S., Van Reeuwijk, J., Simons, D. L., Ding, Q., Wu, K. M., Li, Y., Van Beersum, S., and 10 others. Spata7 is a retinal ciliopathy gene critical for correct RPGRIP1 localization and protein trafficking in the retina. Hum. Molec. Genet. 24: 1584-601, 2015. [PubMed: 25398945, images, related citations] [Full Text]

  4. Feldhaus, B., Kohl, S., Hortnagel, K., Weisschuh, N., Zobor, D. Novel homozygous mutation in the SPATA7 gene causes autosomal recessive retinal degeneration in a consanguineous German family. Ophthalmic Genet. 39: 131-134, 2018. [PubMed: 28481129, related citations] [Full Text]

  5. Gu, S., Thompson, D. A., Srikumari, C. R. S., Lorenz, B., Finckh, U., Nicoletti, A., Murthy, K. R., Rathmann, M., Kumaramanickavel, G., Denton, M. J., Gal, A. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nature Genet. 17: 194-197, 1997. [PubMed: 9326941, related citations] [Full Text]

  6. Kannabiran, C. The spermatogenesis-associated protein-7 (SPATA7) gene--an overview. Ophthalmic Genet. 41: 513-517, 2020. [PubMed: 32799588, related citations] [Full Text]

  7. Li, Y., Wang, H., Peng, J., Gibbs, R. A., Lewis, R. A., Lupski, J. R., Mardon, G., Chen, R. Mutation survey of known LCA genes and loci in the Saudi Arabian population. Invest. Ophthal. Vis. Sci. 50: 1336-1343, 2009. [PubMed: 18936139, images, related citations] [Full Text]

  8. Mackay, D. S., Ocaka, L. A., Borman, A. D., Sergouniotis, P. I., Henderson, R. H., Moradi, P., Robson, A. G., Thompson, D. A., Webster, A. R., Moore, A. T. Screening of SPATA7 in patients with Leber congenital amaurosis and severe childhood-onset retinal dystrophy reveals disease-causing mutations. Invest. Ophthal. Vis. Sci. 52: 3032-3038, 2011. [PubMed: 21310915, related citations] [Full Text]

  9. Matsui, R., McGuigan, D. B., III, Gruzensky, M. L., Aleman, T. S., Schwartz, S. B., Sumaroka, A., Koenekoop, R. K., Cideciyan, A. V., Jacobson, S. G. SPATA7: evolving phenotype from cone-rod dystrophy to retinitis pigmentosa. Ophthalmic Genet. 37: 333-338, 2016. [PubMed: 26854980, images, related citations] [Full Text]

  10. Sengillo, J. D., Lee, W., Bilancia, C. G., Jobanputra, V., Tsang, S. H. Phenotypic expansion and progression of SPATA7-associated retinitis pigmentosa. Doc. Ophthal. 136: 125-133, 2018. [PubMed: 29411205, images, related citations] [Full Text]

  11. Stockton, D. W., Lewis, R. A., Abboud, E. B., Al-Rajhi, A., Jabak, M., Anderson, K. L., Lupski, J. R. A novel locus for Leber congenital amaurosis on chromosome 14q24. Hum. Genet. 103: 328-333, 1998. [PubMed: 9799089, related citations] [Full Text]

  12. Wang, H., den Hollander, A. I., Moayedi, Y., Abulimiti, A., Li, Y., Collin, R. W. J., Hoyng, C. B., Lopez, I., Abboud, E. B., Al-Rajhi, A. A., Bray, M., Lewis, R. A., Lupski, J. R., Mardon, G., Koenekoop, R. K., Chen, R. Mutations in SPATA7 cause Leber congenital amaurosis and juvenile retinitis pigmentosa. Am. J. Hum. Genet. 84: 380-387, 2009. Note: Erratum: Am. J. Hum. Genet. 86: 293 only, 2010. [PubMed: 19268277, images, related citations] [Full Text]


Marla J. F. O'Neill - updated : 06/28/2022
Jane Kelly - updated : 8/16/2011
Marla J. F. O'Neill - updated : 4/6/2010
Marla J. F. O'Neill - updated : 4/13/2009
Carol A. Bocchini - updated : 4/3/2009
Jane Kelly - updated : 6/5/2008
Victor A. McKusick - updated : 9/9/2004
Creation Date:
Victor A. McKusick : 10/14/1999
alopez : 06/28/2022
carol : 05/17/2016
carol : 12/21/2011
terry : 12/21/2011
carol : 8/22/2011
terry : 8/16/2011
carol : 4/6/2010
carol : 3/19/2010
wwang : 4/15/2009
terry : 4/13/2009
carol : 4/3/2009
terry : 4/3/2009
carol : 4/3/2009
carol : 6/5/2008
carol : 9/29/2007
tkritzer : 9/13/2004
tkritzer : 9/10/2004
terry : 9/9/2004
mgross : 3/18/2004
carol : 10/15/1999
carol : 10/15/1999

# 604232

LEBER CONGENITAL AMAUROSIS 3; LCA3


Other entities represented in this entry:

RETINITIS PIGMENTOSA 94, VARIABLE AGE AT ONSET, INCLUDED; RP94, INCLUDED

ORPHA: 65, 791;   DO: 0110331;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q31.3 Retinitis pigmentosa 94, variable age at onset, autosomal recessive 604232 Autosomal recessive 3 SPATA7 609868
14q31.3 Leber congenital amaurosis 3 604232 Autosomal recessive 3 SPATA7 609868

TEXT

A number sign (#) is used with this entry because Leber congenital amaurosis-3 (LCA3) and a form of retinitis pigmentosa with variable age at onset (RP94) are caused by homozygous or compound heterozygous mutation in the SPATA7 gene (609868) on chromosome 14q31.


Description

Autosomal recessive childhood-onset severe retinal dystrophy is a heterogeneous group of disorders affecting rod and cone photoreceptors simultaneously. The most severe cases are termed Leber congenital amaurosis, whereas the less aggressive forms are usually considered retinitis pigmentosa (Gu et al., 1997). SPATA7-associated retinopathy shows a variable age at onset, ranging from infancy to adulthood, as well as phenotypic variability, including intrafamilial differences (Wang et al., 2009; Avila-Fernandez et al., 2011; Feldhaus et al., 2018; Sengillo et al., 2018).

Mackay et al. (2011) concluded that SPATA7 retinopathy is an infantile-onset severe cone-rod dystrophy with early extensive peripheral retinal atrophy but with variable foveal involvement.

For a general phenotypic description and a discussion of genetic heterogeneity of Leber congenital amaurosis, see LCA1 (204000); for retinitis pigmentosa, see 268000.

Reviews

Kannabiran (2020) reviewed reported SPATA7 mutations and the associated phenotypes. The author noted that there were no clear-cut correlations between genotype and phenotype, and that phenotypic heterogeneity had been observed among patients with the same mutation. Clinical variability was also often seen in patients with SPATA7 mutations, with some phenotypes resembling cone-rod dystrophy or choroideremia.


Clinical Features

Stockton et al. (1998) reported a large consanguineous Saudi Arabian kindred (KKESH-019) segregating Leber congenital amaurosis. In addition to poor visual acuity (typically less than 5/200), affected individuals manifested moderate midfacial hypoplasia with enophthalmos, complex vertical, horizontal, and rotatory nystagmus present from early life, moderate hypermetropic refractive errors with astigmatism, and various presentations of esotropia and exotropia. At least 4 individuals had hospital-based electroretinograms (ERGs) which were nonrecordable in both photopic and scotopic components in the first 2 years of life.

Li et al. (2009) reported a Saudi Arabian family (KKESH-060) segregating LCA. The 3 affected sibs had poor vision, nonrecordable ERGs, hypermetropic astigmatism, and infantile nystagmus. Two also showed neuroretinal atrophy and markedly attenuated vessels of the fundi.

Mackay et al. (2011) reported affected members of 5 unrelated families with LCA3. The retina had widespread retinal pigment epithelial atrophy, with minimal pigment migration into the neurosensory retina. Fundus autofluorescence (FAF) imaging showed a parafoveal annulus of increased autofluorescence. High-definition optical coherence tomography (OCT) showed preservation of the inner/outer segment junction at the fovea.

Retinitis Pigmentosa 94, with Variable Age at Onset

Wang et al. (2009) reported 2 unrelated patients with juvenile-onset retinitis pigmentosa (RP) and mutation in the SPATA7 gene. The first was a 7-year-old Portuguese girl (patient 28608) who had excellent (20/20) visual acuity without nystagmus. She developed nyctalopia before age 2 and had 5-degree visual fields on Goldmann perimetry with nondetectable ERGs. The second patient was a French-Canadian man (patient 1348) who was found to have hand-motion vision at age 55 years. He reported initially normal vision in childhood that declined, with the development of night blindness and nystagmus. Examination revealed advanced retinal pigmentary degeneration, with narrow arterioles, optic disc pallor, and mild maculopathy. ERGs were nondetectable and visual fields were reduced to 5 degrees with the V4e target.

Avila-Fernandez et al. (2011) reported 2 Spanish sibs from a consanguineous family with late-onset RP and mutation in the SPATA7 gene. The proband developed night blindness at age 25 years, at which time visual fields were normal. At age 29, she experienced loss of peripheral visual fields, and reexamination showed narrowed retinal vessels and bone-spicule pigmentation in the peripheral retina, with subnormal rod responses on ERG. At age 31, her visual field was limited to 10 degrees, and the ERG showed severely decreased a- and b-wave responses with both scotopic and photopic stimulation. Her affected sib was asymptomatic, but mixed ERG at age 26 showed a moderate reduction in the amplitude of the a-wave and delay in both a- and b-wave latency bilaterally.

Clinical Variability

Matsui et al. (2016) studied a Hispanic boy who presented with a cone-rod dystrophy phenotype that developed into late-stage RP, and who had mutation in the SPATA7 gene. The proband was diagnosed with RP at age 7 years, with retinal pigmentary changes on funduscopy and an abnormal ERG. At age 9, best-corrected visual acuity (BCVA) was 20/25 and 20/32, funduscopy showed a waxy optic disc, minimal vessel attenuation, bull's eye-like change in the macula, and a tigroid appearance of the peripheral retina. Full-field ERG showed reduced rod-mediated responses with nondetectable cone-mediated responses. Visual fields were severely limited to a small central island and midperipheral island of vision. The ERG and visual field findings were consistent with a cone-rod dystrophy. Follow-up over 12 years showed progressive loss of peripheral vision, and by age 17 years, only central vision was detectable. ERG at ages 17 and 21 years showed nondetectable rod function, whereas cone function remained measurable at fixation. OCT showed progressive thinning of the outer nuclear layer (ONL) and rod outer segments (ROS), with the ONL eventually barely detectable and the ROS unmeasurable.

Sengillo et al. (2018) reported a 63-year-old man who had RP with a choroideremia-like phenotype and mutation in the SPATA7 gene. The proband, who had a long history of progressive nyctalopia, visual field constriction, and reduction in visual acuity, and was diagnosed with RP at 31 years of age, presented with a recent subacute decrease in visual acuity of the left eye accompanied by a halo effect around objects. Upon examination, he had BCVAs of 20/30 and 20/60 in the right and left eyes, respectively, and funduscopy showed extensive chorioretinal degeneration of the peripheral retina, progressing toward the macula which contained islands of spared RPE. FAF imaging revealed widespread continuous loss of RPE encroaching on the central macula in both eyes. Spectral domain OCT confirmed those findings, and showed extensive degeneration and sclerosis of the choroid in areas of RPE loss, with focal areas of RPE thickening that were more prominent in the left eye. Full-field ERG revealed completely extinguished scotopic and photopic responses. On follow-up 2 years later, the proband reported no changes in vision, and examination showed BCVAs of 20/25 and 20/60, but progression of disease was evident on SD-OCT and FAF, with FAF confirming a reduction in the area of centrally spared RPE compared to baseline.

Feldhaus et al. (2018) reported a German brother and sister with retinal degeneration and mutation in the SPATA7 gene. Upon examination, the 52-year-old brother was more severely affected than his 48-year-old sister. BCVA in the brother was 20/100 and 20/175, with concentric narrowing to 2 degrees. His sister had BCVAs of 20/160 bilaterally, with visual field narrowing to 40 degrees. ERG responses in the brother were nondetectable, with significantly elevated thresholds for dark adaptation, whereas ERG in the sister showed reduced cone and rod responses, with better-preserved rod function and moderately elevated thresholds for dark adaptation. Color vision testing showed color confusion without assignment to a specific axis in the brother, and a tritanomalous defect in the sister. Both had bone spicule-like pigmentation, more prominent in the brother, and both had attenuated arterioles and optic disc pallor. Central retinal thickness was normal in the brother and reduced in the sister. The clinical diagnosis in the brother was rod-cone dystrophy, whereas in the sister it was cone-rod dystrophy. Age at onset was not reported.


Mapping

Stockton et al. (1998) used a DNA pooling strategy comparing the genotypes of affected to unaffected control pools in a genomewide search for identity by descent in a consanguineous Saudi Arabian LCA family (KKESH-019). A shift to homozygosity was observed in the affected DNA pool compared with the control pool at linked markers D14S606 and D14S610. Testing of markers closely linked to and flanking these loci confirmed linkage with a maximum lod score of 13.29 at theta = 0.0. From these data, the LCA locus, designated LCA3, was assigned to 14q24. This locus and the previously identified loci for LCA were excluded in other Saudi Arabian pedigrees, indicating yet further genetic heterogeneity in LCA.

Using short tandem repeat markers in a Saudi Arabian family (KKESH-060) segregating LCA, Li et al. (2009) found linkage of the disorder to the LCA3 locus at 14q24 (lod score of 3.0). All 3 affected members were homozygous between markers D14S61 and D14S1066, a 13.4-Mb interval, whereas unaffected family members were heterozygous or wildtype. Li et al. (2009) noted that the haplotype in their family was different from that in the family reported by Stockton et al. (1998).

By whole-genome SNP analysis and fine mapping of the distal boundary of the LCA3 locus in 1 affected subject from each of the 2 families with LCA previously studied by Stockton et al. (1998) and Li et al. (2009), Wang et al. (2009) refined the critical region of homozygosity to 3.8 Mb between markers D14S1022 and D14S1005 on chromosome 14q31.3. The critical region contained 9 candidate genes.

In 2 Spanish sibs from a consanguineous family with typical late-onset RP, Avila-Fernandez et al. (2011) performed genomewide linkage analysis followed by homozygosity mapping and identified a 3.7-Mb region on chromosome 14 with a lod score of 2.8 that encompassed the SPATA7 gene.


Molecular Genetics

Leber Congenital Amaurosis 3

In 2 unrelated Saudi Arabian families (KKESH-019 and KKESH-060) with Leber congenital amaurosis (LCA3; 604232) previously reported by Stockton et al. (1998) and Li et al. (2009), respectively, Wang et al. (2009) sequenced 9 candidate genes and identified a homozygous mutation in the SPATA7 gene (R108X; 609868.0001) in family KKESH-060 that segregated with the disease and was not found in 50 Saudi Arabian and 100 European samples. Mutation analysis in additional patients revealed homozygosity for the same R108X mutation in a Dutch LCA patient as well as a frameshift mutation in another LCA patient of Middle Eastern origin (609868.0002). Wang et al. (2009) also identified homozygous SPATA7 mutations in 2 patients with juvenile-onset retinitis pigmentosa (see later).

Mackay et al. (2011) screened all coding exons in the SPATA7 gene in 141 patients diagnosed with LCA or early childhood-onset severe retinal dystrophy and identified 4 disease-causing mutations in 5 families. They concluded that mutations in SPATA7 are a rare cause of childhood retinal dystrophy, accounting for 1.7% of disease in their cohort. Four consanguineous families with LCA, 3 of Pakistani and 1 of Bangladeshi origin, had a homozygous mutation in exon 5 (609868.0007) or exon 8 (609868.0002). In a nonconsanguineous British Caucasian family, 2 brothers had compound heterozygous mutations, one in exon 5 (609868.0005) and the other in exon 12 (609868.0006). One of the brothers had clinical features consistent with LCA, having severe visual loss from early infancy, pendular nystagmus, and sluggish pupillary responses. His brother had a milder phenotype with onset of nystagmus at 8 weeks of age. He was able to fix and follow at this age. When older, he was noted to have severe nyctalopia and constricted visual fields. These symptoms deteriorated significantly from 14 years of age.

Retinitis Pigmentosa 94, Variable Age at Onset

In 2 patients with juvenile-onset retinitis pigmentosa (RP94; see 604232), Wang et al. (2009) identified homozygosity for 2 different different nonsense and frameshift mutations in the SPATA7 gene (609868.0003 and 609868.0004, respectively). Wang et al. (2009) noted that, consistent with the observation that LCA has a more severe clinical phenotype than juvenile RP, the nonsense mutations associated with LCA are located in the middle of the SPATA7 coding region, whereas those associated with juvenile RP are located in the last 2 exons of SPATA7.

In 2 Spanish sibs from a consanguineous family with typical late-onset RP mapping to the SPATA7 locus on chromosome 14, Avila-Fernandez et al. (2011) identified homozygosity for the R85X mutation in the SPATA7 gene (609868.0007), previously reported in affected individuals from 3 families with LCA (Mackay et al., 2011). Avila-Fernandez et al. (2011) suggested that the phenotypic variability might be explained by modifier alleles contributing to penetrance and expressivity, or intronic variants influencing severity.

In a 21-year-old Hispanic man with retinal degeneration that had progressed over 12 years from a cone-rod dystrophy phenotype to a late-stage RP phenotype, Matsui et al. (2016) screened 163 retinal disease-associated genes and identified homozygosity for a 1-bp deletion in the SPATA7 gene (609868.0008).

In a 63-year-old man who had severe RP associated with prominent RPE atrophy and choroidal sclerosis, Sengillo et al. (2018) performed whole-exome sequencing and identified compound heterozygosity for mutations in the SPATA7 gene: a missense mutation (Y367C; 609868.0009) and a 2-bp deletion (609868.0010). An unaffected family member was heterozygous for 1 of the variants, both of which were present at very low minor allele frequency (less than 0.00003) in the gnomAD database. The authors stated that future studies were needed to discern whether unidentified genetic modifiers were involved or whether this represented a phenotypic subset of SPATA7-associated retinal degeneration.

In a German brother and sister with retinal degeneration, diagnosed as rod-cone and cone-rod dystrophy, respectively, Feldhaus et al. (2018) analyzed genomic DNA using a panel of 286 retinal disease-associated genes and identified homozygosity for a missense mutation in the SPATA7 gene (I371T; 609868.0011). The variant, which was found at low minor allele frequency (0.0003249) in the ExAC database, was present in heterozygosity in their 85-year-old mother, who had normal age-related findings on all tests; DNA was unavailable from the father. The authors noted that although the sibs were homozygous for the same mutation, they exhibited phenotypic variability, and thus genotype/phenotype correlation remained difficult.


Nomenclature

Leber congenital amaurosis-13 (612712), which is caused by mutation in the RDH12 gene (608830) on chromosome 14q23.3, was originally thought to be the same as LCA3. However, affected members of the Saudi Arabian family reported by Stockton et al. (1998) do not have mutations in the RDH12 gene.


Animal Model

Eblimit et al. (2015) generated Spata7-knockout mice and observed severe early-onset retinal defects, with a marked reduction in the thickness of the outer nuclear layer compared to wildtype mice. The loss in thickness was progressive, suggesting that photoreceptor cells degenerate in the absence of Spata7 function; other cell types in the mutant retinas were unaffected. Quantification of cone and rod cells per unit area indicated that cone photoreceptor degeneration proceeds at a substantially lower rate compared to rods in Spata7-mutant retinas. Transmission electron microscopy revealed shortened outer segments and disorganization of the disc membranes in mutant retinas compared to wildtype retinas, where the discs were well-organized into stacks. Analysis of rod and cone electroretinography (ERG) responses in the Spata7-null mice showed a decline in rod responses by postnatal day (P) 15 that became more pronounced with age, whereas cone-mediated responses showed only a slight age-dependent decline. Rod function was almost undetectable by age 12 months.

Eblimit et al. (2018) generated a conditional SPATA7-knockout allele to determine which cell type requires Spata7 function for photoreceptor survival. In Spata7 photoreceptor-specific conditional knockout mice, both rod and cone photoreceptor dysfunction and degeneration was observed, characterized by progressive thinning of the outer nuclear layer and reduced response to light. However, RPE-specific deletion of Spata7 did not impair retinal function or cell survival. The authors noted that the alteration in both rod and cone function resulting from loss of Spata7 in photoreceptors was consistent with the clinical phenotypes of LCA and RP observed in patients with SPATA7 mutations.


REFERENCES

  1. Avila-Fernandez, A., Corton, M., Lopez-Molina, M. I., Martin-Garrido, E., Cantalapiedra, D., Fernandez-Sanchez, R., Blanco-Kelly, F., Riveiro-Alvarez, R., Tatu, S. D., Trujillo-Tiebas, M. J., Garcia-Sandoval, B., Ayuso, C., Cremers, F. P. M. Late onset retinitis pigmentosa. Ophthalmology 118: 2523-2524, 2011. [PubMed: 22136677] [Full Text: https://doi.org/10.1016/j.ophtha.2011.07.030]

  2. Eblimit, A., Agrawal, S. A., Thomas, K., Anastassov, I. A., Abulikemu, T., Moayedi, Y., Mardon, G., Chen, R. Conditional loss of Spata7 in photoreceptors causes progressive retinal degeneration in mice. Exp. Eye Res. 166: 120-130, 2018. Note: Erratum: Exp Eye Res. 171: 119, 2018. [PubMed: 29100828] [Full Text: https://doi.org/10.1016/j.exer.2017.10.015]

  3. Eblimit, A., Nguyen, T.-M. T., Chen, Y., Esteve-Rudd, J., Zhong, H., Letteboer, S., Van Reeuwijk, J., Simons, D. L., Ding, Q., Wu, K. M., Li, Y., Van Beersum, S., and 10 others. Spata7 is a retinal ciliopathy gene critical for correct RPGRIP1 localization and protein trafficking in the retina. Hum. Molec. Genet. 24: 1584-601, 2015. [PubMed: 25398945] [Full Text: https://doi.org/10.1093/hmg/ddu573]

  4. Feldhaus, B., Kohl, S., Hortnagel, K., Weisschuh, N., Zobor, D. Novel homozygous mutation in the SPATA7 gene causes autosomal recessive retinal degeneration in a consanguineous German family. Ophthalmic Genet. 39: 131-134, 2018. [PubMed: 28481129] [Full Text: https://doi.org/10.1080/13816810.2017.1318925]

  5. Gu, S., Thompson, D. A., Srikumari, C. R. S., Lorenz, B., Finckh, U., Nicoletti, A., Murthy, K. R., Rathmann, M., Kumaramanickavel, G., Denton, M. J., Gal, A. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nature Genet. 17: 194-197, 1997. [PubMed: 9326941] [Full Text: https://doi.org/10.1038/ng1097-194]

  6. Kannabiran, C. The spermatogenesis-associated protein-7 (SPATA7) gene--an overview. Ophthalmic Genet. 41: 513-517, 2020. [PubMed: 32799588] [Full Text: https://doi.org/10.1080/13816810.2020.1807025]

  7. Li, Y., Wang, H., Peng, J., Gibbs, R. A., Lewis, R. A., Lupski, J. R., Mardon, G., Chen, R. Mutation survey of known LCA genes and loci in the Saudi Arabian population. Invest. Ophthal. Vis. Sci. 50: 1336-1343, 2009. [PubMed: 18936139] [Full Text: https://doi.org/10.1167/iovs.08-2589]

  8. Mackay, D. S., Ocaka, L. A., Borman, A. D., Sergouniotis, P. I., Henderson, R. H., Moradi, P., Robson, A. G., Thompson, D. A., Webster, A. R., Moore, A. T. Screening of SPATA7 in patients with Leber congenital amaurosis and severe childhood-onset retinal dystrophy reveals disease-causing mutations. Invest. Ophthal. Vis. Sci. 52: 3032-3038, 2011. [PubMed: 21310915] [Full Text: https://doi.org/10.1167/iovs.10-7025]

  9. Matsui, R., McGuigan, D. B., III, Gruzensky, M. L., Aleman, T. S., Schwartz, S. B., Sumaroka, A., Koenekoop, R. K., Cideciyan, A. V., Jacobson, S. G. SPATA7: evolving phenotype from cone-rod dystrophy to retinitis pigmentosa. Ophthalmic Genet. 37: 333-338, 2016. [PubMed: 26854980] [Full Text: https://doi.org/10.3109/13816810.2015.1130154]

  10. Sengillo, J. D., Lee, W., Bilancia, C. G., Jobanputra, V., Tsang, S. H. Phenotypic expansion and progression of SPATA7-associated retinitis pigmentosa. Doc. Ophthal. 136: 125-133, 2018. [PubMed: 29411205] [Full Text: https://doi.org/10.1007/s10633-018-9626-1]

  11. Stockton, D. W., Lewis, R. A., Abboud, E. B., Al-Rajhi, A., Jabak, M., Anderson, K. L., Lupski, J. R. A novel locus for Leber congenital amaurosis on chromosome 14q24. Hum. Genet. 103: 328-333, 1998. [PubMed: 9799089] [Full Text: https://doi.org/10.1007/s004390050825]

  12. Wang, H., den Hollander, A. I., Moayedi, Y., Abulimiti, A., Li, Y., Collin, R. W. J., Hoyng, C. B., Lopez, I., Abboud, E. B., Al-Rajhi, A. A., Bray, M., Lewis, R. A., Lupski, J. R., Mardon, G., Koenekoop, R. K., Chen, R. Mutations in SPATA7 cause Leber congenital amaurosis and juvenile retinitis pigmentosa. Am. J. Hum. Genet. 84: 380-387, 2009. Note: Erratum: Am. J. Hum. Genet. 86: 293 only, 2010. [PubMed: 19268277] [Full Text: https://doi.org/10.1016/j.ajhg.2009.02.005]


Contributors:
Marla J. F. O'Neill - updated : 06/28/2022
Jane Kelly - updated : 8/16/2011
Marla J. F. O'Neill - updated : 4/6/2010
Marla J. F. O'Neill - updated : 4/13/2009
Carol A. Bocchini - updated : 4/3/2009
Jane Kelly - updated : 6/5/2008
Victor A. McKusick - updated : 9/9/2004

Creation Date:
Victor A. McKusick : 10/14/1999

Edit History:
alopez : 06/28/2022
carol : 05/17/2016
carol : 12/21/2011
terry : 12/21/2011
carol : 8/22/2011
terry : 8/16/2011
carol : 4/6/2010
carol : 3/19/2010
wwang : 4/15/2009
terry : 4/13/2009
carol : 4/3/2009
terry : 4/3/2009
carol : 4/3/2009
carol : 6/5/2008
carol : 9/29/2007
tkritzer : 9/13/2004
tkritzer : 9/10/2004
terry : 9/9/2004
mgross : 3/18/2004
carol : 10/15/1999
carol : 10/15/1999